XML 85 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Series B Debentures, Net of Current Maturities (Details)
$ in Thousands, ₪ in Millions
 1 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
Sep. 30, 2017
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2020
ILS (₪)
Sep. 30, 2017
ILS (₪)
Series B Debentures, Net of Current Maturities (Details) [Line Items]              
Principal amount $ 60,300 $ 79,200       ₪ 210 ₪ 280
Annual payments $ 9,898 $ 9,898          
Interest rate percentage 3.37%         3.37%  
Debt premium and issuance costs     $ 80        
Debentures fair value     $ 75,192 $ 100,465      
Series B Debentures [Member]              
Series B Debentures, Net of Current Maturities (Details) [Line Items]              
Interest rate percentage   3.37%         3.37%
Debt premium and issuance costs   $ 956          
Debt instrument, covenant description     In accordance with the indenture for the Series B Debentures, the Company is required to meet the following financial covenants: (1) Target shareholders’ equity (excluding minority interest)- above $120 million – as of December 31, 2022, total shareholders’ equity was approximately $400.5 million; and (2) Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) below 65% - as of December 31, 2022 the ratio of net financial indebtedness to net capitalization was (32.96)%.  (3) Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5. As of December 31, 2022, the Target ratio of net financial indebtedness to EBITDA was (1.14). As of December 31, 2022, Sapiens is in compliance with all of its financial covenants.         
Interest expense     $ 2,671 3,337 $ 3,180    
Amortization of debt issuance costs     $ 85 $ 106 $ 134